183 related articles for article (PubMed ID: 30577630)
1. Gemcitabine Induces Microvesicle Particle Release in a Platelet-Activating Factor-Receptor-Dependent Manner via Modulation of the MAPK Pathway in Pancreatic Cancer Cells.
Thyagarajan A; Kadam SM; Liu L; Kelly LE; Rapp CM; Chen Y; Sahu RP
Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30577630
[TBL] [Abstract][Full Text] [Related]
2. Platelet-Activating Factor-Receptor Signaling Mediates Targeted Therapies-Induced Microvesicle Particles Release in Lung Cancer Cells.
Chauhan SJ; Thyagarajan A; Chen Y; Travers JB; Sahu RP
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33198218
[TBL] [Abstract][Full Text] [Related]
3. Topical application of gemcitabine generates microvesicle particles in human and murine skin.
Thyagarajan A; Awasthi K; Rapp CM; Johnson RM; Chen Y; Miller KLR; Travers JB; Sahu RP
Biofactors; 2022 Nov; 48(6):1295-1304. PubMed ID: 36504167
[TBL] [Abstract][Full Text] [Related]
4. UVB Generates Microvesicle Particle Release in Part Due to Platelet-activating Factor Signaling.
Bihl JC; Rapp CM; Chen Y; Travers JB
Photochem Photobiol; 2016 May; 92(3):503-6. PubMed ID: 26876152
[TBL] [Abstract][Full Text] [Related]
5. Ginkgolide B enhances gemcitabine sensitivity in pancreatic cancer cell lines via inhibiting PAFR/NF-кB pathway.
Lou C; Lu H; Ma Z; Liu C; Zhang Y
Biomed Pharmacother; 2019 Jan; 109():563-572. PubMed ID: 30399592
[TBL] [Abstract][Full Text] [Related]
6. Cigarette smoke exposure inhibits contact hypersensitivity via the generation of platelet-activating factor agonists.
Sahu RP; Petrache I; Van Demark MJ; Rashid BM; Ocana JA; Tang Y; Yi Q; Turner MJ; Konger RL; Travers JB
J Immunol; 2013 Mar; 190(5):2447-54. PubMed ID: 23355733
[TBL] [Abstract][Full Text] [Related]
7. Keratinocyte-derived microvesicle particles mediate ultraviolet B radiation-induced systemic immunosuppression.
Liu L; Awoyemi AA; Fahy KE; Thapa P; Borchers C; Wu BY; McGlone CL; Schmeusser B; Sattouf Z; Rohan CA; Williams AR; Cates EE; Knisely C; Kelly LE; Bihl JC; Cool DR; Sahu RP; Wang J; Chen Y; Rapp CM; Kemp MG; Johnson RM; Travers JB
J Clin Invest; 2021 May; 131(10):. PubMed ID: 33830943
[TBL] [Abstract][Full Text] [Related]
8. Expression of the platelet-activating factor receptor enhances benzyl isothiocyanate-induced apoptosis in murine and human melanoma cells.
Sahu RP
Mol Med Rep; 2015 Jul; 12(1):394-400. PubMed ID: 25695262
[TBL] [Abstract][Full Text] [Related]
9. Platelet-activating factor receptor mediates oxidized low density lipoprotein-induced migration of bone marrow-derived mesenchymal stem cells.
Shin SH; Song HY; Kim MY; Do EK; Kim KH; Kim JH
Cell Physiol Biochem; 2010; 26(4-5):689-98. PubMed ID: 21063106
[TBL] [Abstract][Full Text] [Related]
10. New Insights Into the Pathologic Roles of the Platelet-Activating Factor System.
Travers JB; Rohan JG; Sahu RP
Front Endocrinol (Lausanne); 2021; 12():624132. PubMed ID: 33796070
[TBL] [Abstract][Full Text] [Related]
11. Acute ethanol exposure stimulates microvesicle particle generation in keratinocytes.
Awoyemi AA; Borchers C; Liu L; Chen Y; Rapp CM; Brewer CA; Elased R; Travers JB
Toxicol Lett; 2022 Feb; 355():100-105. PubMed ID: 34801640
[TBL] [Abstract][Full Text] [Related]
12. Systemic chemotherapy is modulated by platelet-activating factor-receptor agonists.
Sahu RP; Ferracini M; Travers JB
Mediators Inflamm; 2015; 2015():820543. PubMed ID: 25922565
[TBL] [Abstract][Full Text] [Related]
13. Thermal Burn Injury Generates Bioactive Microvesicles: Evidence for a Novel Transport Mechanism for the Lipid Mediator Platelet-Activating Factor (PAF) That Involves Subcellular Particles and the PAF Receptor.
Liu L; Fahy KE; Awoyemi AA; Thapa P; Kelly LE; Chen J; Bihl JC; Cool DR; Chen Y; Rapp CM; Johnson RM; Travers JB
J Immunol; 2020 Jul; 205(1):193-201. PubMed ID: 32434939
[TBL] [Abstract][Full Text] [Related]
14. Fructose-1,6-bisphosphatase Inhibits ERK Activation and Bypasses Gemcitabine Resistance in Pancreatic Cancer by Blocking IQGAP1-MAPK Interaction.
Jin X; Pan Y; Wang L; Ma T; Zhang L; Tang AH; Billadeau DD; Wu H; Huang H
Cancer Res; 2017 Aug; 77(16):4328-4341. PubMed ID: 28720574
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia increases resistance of human pancreatic cancer cells to apoptosis induced by gemcitabine.
Yokoi K; Fidler IJ
Clin Cancer Res; 2004 Apr; 10(7):2299-306. PubMed ID: 15073105
[TBL] [Abstract][Full Text] [Related]
16. The MAPK-activated protein kinase 2 mediates gemcitabine sensitivity in pancreatic cancer cells.
Köpper F; Binkowski AM; Bierwirth C; Dobbelstein M
Cell Cycle; 2014; 13(6):884-9. PubMed ID: 24556918
[TBL] [Abstract][Full Text] [Related]
17. Topical Photodynamic Therapy Generates Bioactive Microvesicle Particles: Evidence for a Pathway Involved in Immunosuppressive Effects.
Oyebanji OA; Brewer C; Bayless S; Schmeusser B; Corbin DA; Sulentic CEW; Sherwin CMT; Chen Y; Rapp CM; Cates EE; Long Y; Travers JB; Rohan CA
J Invest Dermatol; 2023 Jul; 143(7):1279-1288.e9. PubMed ID: 36708950
[TBL] [Abstract][Full Text] [Related]
18. Involvement of p38 mitogen-activated protein kinase in gemcitabine-induced apoptosis in human pancreatic cancer cells.
Habiro A; Tanno S; Koizumi K; Izawa T; Nakano Y; Osanai M; Mizukami Y; Okumura T; Kohgo Y
Biochem Biophys Res Commun; 2004 Mar; 316(1):71-7. PubMed ID: 15003513
[TBL] [Abstract][Full Text] [Related]
19. Endothelial progenitor cells express PAF receptor and respond to PAF via Ca(2+)-dependent signaling.
Balestrieri ML; Giovane A; Milone L; Servillo L
Biochim Biophys Acta; 2010 Oct; 1801(10):1123-32. PubMed ID: 20637897
[TBL] [Abstract][Full Text] [Related]
20. Platelet-activating factor receptor (PAF-R)-dependent pathways control tumour growth and tumour response to chemotherapy.
de Oliveira SI; Andrade LN; Onuchic AC; Nonogaki S; Fernandes PD; Pinheiro MC; Rohde CB; Chammas R; Jancar S
BMC Cancer; 2010 May; 10():200. PubMed ID: 20465821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
